Your session is about to expire
← Back to Search
PCIP for Childhood PTSD
Study Summary
This trial studies a brief PTSD intervention for children ages 6-11 and their caregivers, delivered via telehealth, to measure effectiveness and patient satisfaction.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have thought about killing yourself and made a plan to do so within the last two weeks, or you have tried to kill yourself within the last month.
- Group 1: PCIP for youth aged 6 to 11
- Group 2: Waitlist Treatment as Usual
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are individuals aged 70 and younger qualified to participate in this trial?
"As per the rules, this clinical trial is limited to participants that are between 6 and 11 years of age."
Is registration for this research study still open to participants?
"Evidence on clinicaltrials.gov reveals that this particular medical trial, which was first posted during December 15th 2022 and its latest update being from November 30th 2022, is no longer recruiting patients. Conversely, there are 1173 other trials looking for participants as of this moment."
Could I possibly fulfill the requirements of this experiment?
"Enrolment into this medical study is limited to individuals between ages 6 and 11 suffering from post-traumatic stress disorder. Currently, there are 20 possible openings for participants."
What is the purpose of this investigation?
"This clinical trial takes place over one month and the primary outcome measures is a change in self-reported arousal. Secondary outcomes include changes to depression symptoms (as measured by CESD-C), anxiety symptoms (measured via RCADS) and positive parenting practices (via Alabama Parenting Questionnaire). All metrics are scored on an interval between 0 and 60, 141, or 210 respectively with higher scores indicating greater severity/frequency of the relevant metric."
Share this study with friends
Copy Link
Messenger